These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17470659)

  • 1. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.
    Davies TA; Page MG; Shang W; Andrew T; Kania M; Bush K
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2621-4. PubMed ID: 17470659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
    Walkty A; Adam HJ; Laverdière M; Karlowsky JA; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):348-55. PubMed ID: 21353964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae.
    Moisan H; Pruneau M; Malouin F
    J Antimicrob Chemother; 2010 Apr; 65(4):713-6. PubMed ID: 20097788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action and antimicrobial activity of ceftobiprole.
    Morosini MI; Díez-Aguilar M; Cantón R
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 3(Suppl 3):3-10. PubMed ID: 31364335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins.
    Kumar KM; Anbarasu A; Ramaiah S
    Mol Biosyst; 2014 Apr; 10(4):891-900. PubMed ID: 24503740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa.
    Davies TA; Shang W; Bush K; Flamm RK
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1510-2. PubMed ID: 18250190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftobiprole: an extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin.
    Anderson SD; Gums JG
    Ann Pharmacother; 2008 Jun; 42(6):806-16. PubMed ID: 18477729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    Vidaillac C; Rybak MJ
    Pharmacotherapy; 2009 May; 29(5):511-25. PubMed ID: 19397461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights into Ceftobiprole Inhibition of Pseudomonas aeruginosa Penicillin-Binding Protein 3.
    Kumar V; Tang C; Bethel CR; Papp-Wallace KM; Wyatt J; Desarbre E; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of ceftobiprole against Gram-positive cocci.
    Betriu C; Culebras E; Gómez M; López-Fabal F; Rodríguez-Avial I; Picazo JJ
    Int J Antimicrob Agents; 2010 Aug; 36(2):111-3. PubMed ID: 20554163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Lascols C; Legrand P; Mérens A; Leclercq R; Muller-Serieys C; Drugeon HB; Kitzis MD; Reverdy ME; Roussel-Delvallez M; Moubareck C; Brémont S; Miara A; Gjoklaj M; Soussy CJ
    Int J Antimicrob Agents; 2011 Mar; 37(3):235-9. PubMed ID: 21295447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
    Yokota T; Suzuki E; Arai K
    Drugs Exp Clin Res; 1988; 14(8):495-500. PubMed ID: 3073932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
    Barbour A; Schmidt S; Rand KH; Derendorf H
    Int J Antimicrob Agents; 2009 Jul; 34(1):1-7. PubMed ID: 19261449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.
    Davies TA; He W; Bush K; Flamm RK
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4510-2. PubMed ID: 20696872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria.
    Asli A; Brouillette E; Krause KM; Nichols WW; Malouin F
    Antimicrob Agents Chemother; 2016 Feb; 60(2):752-6. PubMed ID: 26574008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.
    Rossolini GM; Dryden MS; Kozlov RS; Quintana A; Flamm RK; Läuffer JM; Lee E; Morrissey I; CLASS Study Group
    J Antimicrob Chemother; 2011 Jan; 66(1):151-9. PubMed ID: 21051375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.